8-K
Current Report
Niagen Bioscience, Inc. Filed Acc 0001628280-23-008497
Bylaws or fiscal year change
- Item 5.03 Amendments to articles or bylaws; change in fiscal year
From the SEC's structured data for this filing
Loading cdxc-20230316.htm…